# A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer

> **NCT00680940** · PHASE2 · COMPLETED · sponsor: **Cadila Pharnmaceuticals** · enrollment: 221 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** Paclitaxel & Cisplatin
- **BIOLOGICAL:** Mycobacterium w.

## Key facts

- **NCT ID:** NCT00680940
- **Lead sponsor:** Cadila Pharnmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 221 (ACTUAL)
- **Last updated:** 2012-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00680940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00680940, "A Study of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin in Advanced Non Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00680940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*